Have the results of the ancillary study of the VITAL trial, demonstrating that Vitamin D3 supplementation did not reduce the incident rate of fractures in generally healthy midlife and older adults, changed how you prescribe Vitamin D?

The VITAL Study concluded that vitamin D3 supplementation did not reduce the incident rate of fractures in generally healthy midlife and older adults. Have the results of this study changed how you recommend and prescribe Vitamin D?

• Yes – I recommend Vitamin D3 much less frequently now.
• Yes – I no longer recommend Vitamin D3 unless patients have overtly low Vitamin D and osteoporosis.
• No – In my practice, I only treat people with osteoporosis (which were not included in the study) so the study results do not apply to my patient population.
• No – I don’t think this study was well designed and therefore do not believe in the accuracy of the results.
• No – The results of this study differ from prior studies of Vitamin D and fracture prevention so I am choosing to continue my current Vitamin D prescribing patterns.
• Other